产品标题 产品货号 产品规格 厂家
COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) (COPS2), transcript variant 2 from ORIGENE TECHNOLOGIESLY428394100 ugORIGENE TECHNOLOGIES
COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis) (COPS3), transcript variant 2 from ORIGENE TECHNOLOGIESLY434211100 ugORIGENE TECHNOLOGIES
COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis) (COPS8), transcript variant 1 from ORIGENE TECHNOLOGIESLY416469100 ugORIGENE TECHNOLOGIES
COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis) (COPS8), transcript variant 2 from ORIGENE TECHNOLOGIESLY404971100 ugORIGENE TECHNOLOGIES
COP9 constitutive photomorphogenic homolog subunit 7B (Arabidopsis) (COPS7B) from ORIGENE TECHNOLOGIESLY411596100 ugORIGENE TECHNOLOGIES
COPE - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4035311 kitORIGENE TECHNOLOGIES
Cope - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5036781 kitORIGENE TECHNOLOGIES
COPE Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30353110 ugORIGENE TECHNOLOGIES
COPG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4090181 kitORIGENE TECHNOLOGIES
COPG2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4233721 kitORIGENE TECHNOLOGIES
Copg1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5036791 kitORIGENE TECHNOLOGIES
Copg2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5036801 kitORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6274855x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6276715x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6278165x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6376085x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6379845x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6387435x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6390765x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6491435x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS8150995x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular from ORIGENE TECHNOLOGIESCS6521525x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, follicular, recurrent from ORIGENE TECHNOLOGIESCS5348305x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin from ORIGENE TECHNOLOGIESCS8065385x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin from ORIGENE TECHNOLOGIESCS8109645x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin from ORIGENE TECHNOLOGIESCS6246935x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS8040555x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS8090505x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS8090515x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS8120895x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS6297255x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS6324215x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular lymphocyte predominant from ORIGENE TECHNOLOGIESCS6433435x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular sclerosing from ORIGENE TECHNOLOGIESCS7040415x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular sclerosing from ORIGENE TECHNOLOGIESCS8005885x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular sclerosing from ORIGENE TECHNOLOGIESCS8028865x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, Hodgkin, nodular sclerosing from ORIGENE TECHNOLOGIESCS8060085x5umORIGENE TECHNOLOGIES
Npy6r - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5111881 kitORIGENE TECHNOLOGIES
NQO1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2006201 kitORIGENE TECHNOLOGIES
NQO1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN200620BN1 kitORIGENE TECHNOLOGIES
NQO1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN200620LP1 kitORIGENE TECHNOLOGIES
NQO1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN200620RB1 kitORIGENE TECHNOLOGIES
NQO2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2028891 kitORIGENE TECHNOLOGIES
NQO2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202889BN1 kitORIGENE TECHNOLOGIES
NQO2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202889LP1 kitORIGENE TECHNOLOGIES
NQO2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202889RB1 kitORIGENE TECHNOLOGIES
NQO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4006201 kitORIGENE TECHNOLOGIES
NQO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4028891 kitORIGENE TECHNOLOGIES
Nqo1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5111891 kitORIGENE TECHNOLOGIES
Nqo2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5111901 kitORIGENE TECHNOLOGIES
 |< < 2161 2162 2163 2164 2165 2166 2167 2168 2169 > >| 第 2163/6274 页